{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:17:20Z","timestamp":1792275440514,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371034"],"award-info":[{"award-number":["82371034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04580-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:58:20Z","timestamp":1768993100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors and survival analysis in high-risk penetrating keratoplasty: a retrospective cohort study in 220 patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Li","family":"li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"2","key":"4580_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","volume":"134","author":"P Gain","year":"2016","unstructured":"Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, Thuret G. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167\u201373.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"4580_CR2","doi-asserted-by":"publisher","first-page":"P247","DOI":"10.1016\/j.ophtha.2023.12.039","volume":"131","author":"SI Mian","year":"2024","unstructured":"Mian SI, Viriya ET, Ahmad S, Amescua G, Cheung AY, Choi DS, Jhanji V, Lin A, Rhee MK, Mah FS, et al. Corneal edema and opacification preferred practice Pattern\u00ae. Ophthalmology. 2024;131(4):P247\u2013305.","journal-title":"Ophthalmology"},{"issue":"9 Suppl 1","key":"4580_CR3","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1097\/ICO.0b013e31812f685c","volume":"26","author":"DT Tan","year":"2007","unstructured":"Tan DT, Mehta JS. Future directions in lamellar corneal transplantation. Cornea. 2007;26(9 Suppl 1):S21\u201328.","journal-title":"Cornea"},{"issue":"9827","key":"4580_CR4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60437-1","volume":"379","author":"DT Tan","year":"2012","unstructured":"Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. 2012;379(9827):1749\u201361.","journal-title":"Lancet"},{"issue":"5","key":"4580_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/ICO.0b013e3181c29705","volume":"29","author":"S Fukuoka","year":"2010","unstructured":"Fukuoka S, Honda N, Ono K, Mimura T, Usui T, Amano S. Extended long-term results of penetrating keratoplasty for keratoconus. Cornea. 2010;29(5):528\u201330.","journal-title":"Cornea"},{"issue":"7","key":"4580_CR6","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S0161-6420(03)00463-9","volume":"110","author":"RW Thompson Jr","year":"2003","unstructured":"Thompson RW Jr., Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110(7):1396\u2013402.","journal-title":"Ophthalmology"},{"issue":"2","key":"4580_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00003226-200103000-00002","volume":"20","author":"M Sit","year":"2001","unstructured":"Sit M, Weisbrod DJ, Naor J, Slomovic AR. Corneal graft outcome study. Cornea. 2001;20(2):129\u201333.","journal-title":"Cornea"},{"issue":"6","key":"4580_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/00003226-200308000-00013","volume":"22","author":"MC Bartels","year":"2003","unstructured":"Bartels MC, Doxiadis II, Colen TP, Beekhuis WH. Long-term outcome in high-risk corneal transplantation and the influence of HLA-A and HLA-B matching. Cornea. 2003;22(6):552\u20136.","journal-title":"Cornea"},{"issue":"10","key":"4580_CR9","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","volume":"110","author":"The collaborative corneal transplantation studies (CCTS)","year":"1992","unstructured":"The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The collaborative corneal transplantation studies research group. Arch Ophthalmol. 1992;110(10):1392\u2013403.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"4580_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/bjo.86.9.945","volume":"86","author":"JC Hill","year":"2002","unstructured":"Hill JC. High risk corneal grafting. Br J Ophthalmol. 2002;86(9):945.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"4580_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s003470050146","volume":"94","author":"T Reinhard","year":"1997","unstructured":"Reinhard T, Sundmacher R, Godehardt E, Heering P. [Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor]. Ophthalmologe. 1997;94(7):496\u2013500.","journal-title":"Ophthalmologe"},{"issue":"6","key":"4580_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00003226-199511000-00015","volume":"14","author":"M Ghoraishi","year":"1995","unstructured":"Ghoraishi M, Akova YA, Tugal-Tutkun I, Foster CS. Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea. 1995;14(6):610\u20133.","journal-title":"Cornea"},{"issue":"12","key":"4580_CR13","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1097\/ICO.0b013e31821e65b3","volume":"30","author":"AK Maier","year":"2011","unstructured":"Maier AK, Ozl\u00fcgedik S, Rottler J, Heussen FM, Klamann MK, Huber KK, Joussen AM, Winterhalter S. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis. Cornea. 2011;30(12):1398\u2013405.","journal-title":"Cornea"},{"issue":"3","key":"4580_CR14","first-page":"372","volume":"10","author":"AK Tourkmani","year":"2017","unstructured":"Tourkmani AK, S\u00e1nchez-Huerta V, De Wit G, Mart\u00ednez JD, Mingo D, Mahillo-Fern\u00e1ndez I, Jim\u00e9nez-Alfaro I. Weighing of risk factors for penetrating keratoplasty graft failure: application of risk score system. Int J Ophthalmol. 2017;10(3):372\u20137.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"4580_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10792-007-9177-z","volume":"28","author":"FR Ghosheh","year":"2008","unstructured":"Ghosheh FR, Cremona FA, Rapuano CJ, Cohen EJ, Ayres BD, Hammersmith KM, Raber IM, Laibson PR. Trends in penetrating keratoplasty in the united States 1980\u20132005. Int Ophthalmol. 2008;28(3):147\u201353.","journal-title":"Int Ophthalmol"},{"issue":"10","key":"4580_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/02713683.2020.1737716","volume":"45","author":"MT Pluzsik","year":"2020","unstructured":"Pluzsik MT, Seitz B, Flockerzi FA, Langenbucher A, T\u00f3th G, Bohle RM, Szentm\u00e1ry N. Changing trends in penetrating keratoplasty indications between 2011 and 2018 - Histopathology of 2123 corneal buttons in a single center in Germany. Curr Eye Res. 2020;45(10):1199\u2013204.","journal-title":"Curr Eye Res"},{"issue":"1","key":"4580_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12886-024-03708-y","volume":"24","author":"L Li","year":"2024","unstructured":"Li L, Peng Y, Lv L, Li N, Dai H, Yan C, Jin T, Luo F, Wang W, Li S, et al. Changing indications for and trends of keratoplasty in a tertiary comprehensive hospital in Northern part of China from 2002 to 2021: a 20-year review. BMC Ophthalmol. 2024;24(1):456.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"4580_CR18","first-page":"492","volume":"4","author":"JY Wang","year":"2011","unstructured":"Wang JY, Xie LX, Song XS, Zhao J. Trends in the indications for penetrating keratoplasty in Shandong, 2005\u20132010. Int J Ophthalmol. 2011;4(5):492\u20137.","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"4580_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4103\/IJO.IJO_724_23","volume":"72","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Parmar GS, Kapur N, Gomase SN, Khurana A, Borde P, Acharya M, Sangwan V, Majumdar A. Trends in keratoplasty from central and Northern India. Part II: types of keratoplasty. Indian J Ophthalmol. 2024;72(6):831\u20137.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"4580_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/ICO.0000000000000291","volume":"34","author":"M Ziaei","year":"2015","unstructured":"Ziaei M, Manzouri B. Topical cyclosporine in corneal transplantation. Cornea. 2015;34(1):110\u20135.","journal-title":"Cornea"},{"issue":"10","key":"4580_CR21","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/bjo.2008.143024","volume":"92","author":"M Unal","year":"2008","unstructured":"Unal M, Y\u00fccel I. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts. Br J Ophthalmol. 2008;92(10):1411\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"4580_CR22","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1136\/bjo.2009.172577","volume":"94","author":"MA Javadi","year":"2010","unstructured":"Javadi MA, Feizi S, Karbasian A, Rastegarpour A. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes. Br J Ophthalmol. 2010;94(11):1464\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4580_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1034\/j.1600-0420.2001.790308.x","volume":"79","author":"K Inoue","year":"2001","unstructured":"Inoue K, Amano S, Oshika T, Tsuru T. Risk factors for corneal graft failure and rejection in penetrating keratoplasty. Acta Ophthalmol Scand. 2001;79(3):251\u20135.","journal-title":"Acta Ophthalmol Scand"},{"issue":"17","key":"4580_CR24","doi-asserted-by":"publisher","first-page":"e15274","DOI":"10.1097\/MD.0000000000015274","volume":"98","author":"RI Barraquer","year":"2019","unstructured":"Barraquer RI, Pareja-Aric\u00f2 L, G\u00f3mez-Benlloch A, Michael R. Risk factors for graft failure after penetrating keratoplasty. Med (Baltim). 2019;98(17):e15274.","journal-title":"Med (Baltim)"},{"issue":"3","key":"4580_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0161-6420(92)31960-8","volume":"99","author":"KA Williams","year":"1992","unstructured":"Williams KA, Roder D, Esterman A, Muehlberg SM, Coster DJ. Factors predictive of corneal graft survival. Report from the Australian corneal graft registry. Ophthalmology. 1992;99(3):403\u201314.","journal-title":"Ophthalmology"},{"issue":"12","key":"4580_CR26","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.ophtha.2012.06.050","volume":"119","author":"AS Majander","year":"2012","unstructured":"Majander AS, Lindahl PM, Vasara LK, Krootila K. Anterior segment optical coherence tomography in congenital corneal opacities. Ophthalmology. 2012;119(12):2450\u20137.","journal-title":"Ophthalmology"},{"issue":"1","key":"4580_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijmr.IJMR_141_19","volume":"150","author":"R Singh","year":"2019","unstructured":"Singh R, Gupta N, Vanathi M, Tandon R. Corneal transplantation in the modern era. Indian J Med Res. 2019;150(1):7\u201322.","journal-title":"Indian J Med Res"},{"issue":"3","key":"4580_CR28","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0041-1345(99)00010-X","volume":"31","author":"JW Streilein","year":"1999","unstructured":"Streilein JW, Yamada J, Dana MR, Ksander BR. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transpl Proc. 1999;31(3):1472\u20135.","journal-title":"Transpl Proc"},{"issue":"4 Pt 2","key":"4580_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1600-6135.2005.00831.x","volume":"5","author":"FK Port","year":"2005","unstructured":"Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the united States, 2004. Am J Transpl. 2005;5(4 Pt 2):843\u20139.","journal-title":"Am J Transpl"},{"issue":"9","key":"4580_CR30","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.ophtha.2006.02.058","volume":"113","author":"S Pramanik","year":"2006","unstructured":"Pramanik S, Musch DC, Sutphin JE, Farjo AA. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology. 2006;113(9):1633\u20138.","journal-title":"Ophthalmology"},{"key":"4580_CR31","doi-asserted-by":"publisher","first-page":"100768","DOI":"10.1016\/j.preteyeres.2019.07.001","volume":"73","author":"D Hos","year":"2019","unstructured":"Hos D, Matthaei M, Bock F, Maruyama K, Notara M, Clahsen T, Hou Y, Le VNH, Salabarria AC, Horstmann J, et al. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res. 2019;73:100768.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"4580_CR32","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","volume":"101","author":"MG Maguire","year":"1994","unstructured":"Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE, Schwartz A. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative corneal transplantation studies research group. Ophthalmology. 1994;101(9):1536\u201347.","journal-title":"Ophthalmology"},{"issue":"1","key":"4580_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00004397-200201000-00015","volume":"42","author":"VM Tham","year":"2002","unstructured":"Tham VM, Abbott RL. Corneal graft rejection: recent updates. Int Ophthalmol Clin. 2002;42(1):105\u201313.","journal-title":"Int Ophthalmol Clin"},{"issue":"8","key":"4580_CR34","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Cao J, Chen L, Liu Y, Maruyama K, Jackson D, Kruse FE, Wiegand SJ, Dana MR, Streilein JW. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45(8):2666\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"4580_CR35","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1097\/ICO.0000000000002736","volume":"40","author":"C Cursiefen","year":"2021","unstructured":"Cursiefen C, Hos D. Cutting edge: novel treatment options targeting corneal neovascularization to improve High-Risk corneal graft survival. Cornea. 2021;40(12):1512\u20138.","journal-title":"Cornea"},{"issue":"1","key":"4580_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/ICO.0b013e318158f6ad","volume":"27","author":"HS Uy","year":"2008","unstructured":"Uy HS, Chan PS, Ang RE. Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome. Cornea. 2008;27(1):70\u20133.","journal-title":"Cornea"},{"key":"4580_CR37","doi-asserted-by":"crossref","unstructured":"Dastjerdi MH, Al-Arfaj KM, Nallasamy N, Hamrah P, Jurkunas UV, Pineda R 2nd, Pavan-Langston D, Dana R. Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol. 2009;127(4):381\u20139.","DOI":"10.1001\/archophthalmol.2009.18"},{"key":"4580_CR38","doi-asserted-by":"publisher","first-page":"101993","DOI":"10.1016\/j.ajoc.2024.101993","volume":"33","author":"N Rangu","year":"2024","unstructured":"Rangu N, Riaz KM. Mitomycin intravascular chemoembolization (MICE) to treat corneal vascularization prior to penetrating keratoplasty. Am J Ophthalmol Case Rep. 2024;33:101993.","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"4580_CR39","first-page":"9","volume":"29","author":"SZ Addeen","year":"2023","unstructured":"Addeen SZ, Oyoun Z, Alfhaily H, Anbari A. Outcomes of mitomycin C intravascular chemoembolization (MICE) in refractory corneal neovascularization after failed keratoplasty. Digit J Ophthalmol. 2023;29(1):9\u201313.","journal-title":"Digit J Ophthalmol"},{"issue":"6b","key":"4580_CR40","first-page":"4271","volume":"21","author":"B Krammer","year":"2001","unstructured":"Krammer B. Vascular effects of photodynamic therapy. Anticancer Res. 2001;21(6b):4271\u20137.","journal-title":"Anticancer Res"},{"issue":"4","key":"4580_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3928\/1081-597X-19890701-09","volume":"5","author":"JW Cowden","year":"1989","unstructured":"Cowden JW, Copeland RA Jr., Schneider MS. Large diameter therapeutic penetrating keratoplasties. Refract Corneal Surg. 1989;5(4):244\u20138.","journal-title":"Refract Corneal Surg"},{"issue":"3","key":"4580_CR42","first-page":"461","volume":"11","author":"PM Cherry","year":"1979","unstructured":"Cherry PM, Pashby RC, Tadros ML, Wolf A, Chipman ML, Basu PK, Dixon WS, Hunter WS, Thompson GA. An analysis of corneal transplantation: I\u2013graft clarity. Ann Ophthalmol. 1979;11(3):461\u20139.","journal-title":"Ann Ophthalmol"},{"issue":"3","key":"4580_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00003226-200304000-00021","volume":"22","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003;22(3):273\u201381.","journal-title":"Cornea"},{"issue":"3","key":"4580_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/ICO.0b013e3181b6489e","volume":"29","author":"HM Skeens","year":"2010","unstructured":"Skeens HM, Holland EJ. Large-diameter penetrating keratoplasty: indications and outcomes. Cornea. 2010;29(3):296\u2013301.","journal-title":"Cornea"},{"issue":"5","key":"4580_CR45","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jfo.2021.11.001","volume":"45","author":"W Boucenna","year":"2022","unstructured":"Boucenna W, Bourges JL. [Penetrating keratoplasty]. J Fr Ophtalmol. 2022;45(5):543\u201358.","journal-title":"J Fr Ophtalmol"},{"issue":"11","key":"4580_CR46","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1007\/s00417-022-05691-w","volume":"260","author":"E Debourdeau","year":"2022","unstructured":"Debourdeau E, Builles N, Couderc G, Boulhic J, Chamard C, Villain M, Babeau F, Daien V. Risk factors of rejection after penetrating keratoplasty: a retrospective monocentric study. Graefes Arch Clin Exp Ophthalmol. 2022;260(11):3627\u201338.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"4580_CR47","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1055\/a-1396-4787","volume":"239","author":"R Alfaro Rangel","year":"2022","unstructured":"Alfaro Rangel R, Szentm\u00e1ry N, Lepper S, Milioti G, Daas L, Langenbucher A, Seitz B. Large-Diameter penetrating keratoplasties are mostly due to very severe infectious keratitis and cannot always prevent secondary enucleation. Klin Monbl Augenheilkd. 2022;239(11):1361\u20138.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"4","key":"4580_CR48","first-page":"448","volume":"5","author":"A Dursun","year":"2012","unstructured":"Dursun A, Arici MK, Dursun F, Ozec AV, Toker MI, Erdogan H, Topalkara A. Comparison of the effects of bevacizumab and Ranibizumab injection on corneal angiogenesis in an alkali burn induced model. Int J Ophthalmol. 2012;5(4):448\u201351.","journal-title":"Int J Ophthalmol"},{"key":"4580_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajo.2019.12.013","volume":"212","author":"ME Ara\u00fajo","year":"2020","unstructured":"Xavier Dos Santos, Ara\u00fajo ME, Santos NC, Souza LB, Sato EH, de Freitas D. Primary pediatric keratoplasty: Etiology, graft Survival, and visual outcome. Am J Ophthalmol. 2020;212:162\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"4580_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/IIO.0b013e3181694901","volume":"48","author":"AS Chan","year":"2008","unstructured":"Chan AS, Colby K. Update on pediatric keratoplasty. Int Ophthalmol Clin. 2008;48(2):25\u201333.","journal-title":"Int Ophthalmol Clin"},{"issue":"8","key":"4580_CR51","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0161-6420(95)30900-1","volume":"102","author":"MR Dana","year":"1995","unstructured":"Dana MR, Moyes AL, Gomes JA, Rosheim KM, Schaumberg DA, Laibson PR, Holland EJ, Sugar A, Sugar J. The indications for and outcome in pediatric keratoplasty. A multicenter study. Ophthalmology. 1995;102(8):1129\u201338.","journal-title":"Ophthalmology"},{"key":"4580_CR52","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2147\/OPTH.S65412","volume":"8","author":"AL Yu","year":"2014","unstructured":"Yu AL, Kaiser M, Schaumberger M, Messmer E, Kook D, Welge-Lussen U. Perioperative and postoperative risk factors for corneal graft failure. Clin Ophthalmol. 2014;8:1641\u20137.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"4580_CR53","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ophtha.2008.12.050","volume":"116","author":"A Sugar","year":"2009","unstructured":"Sugar A, Tanner JP, Dontchev M, Tennant B, Schultze RL, Dunn SP, Lindquist TD, Gal RL, Beck RW, Kollman C, et al. Recipient risk factors for graft failure in the cornea donor study. Ophthalmology. 2009;116(6):1023\u20138.","journal-title":"Ophthalmology"},{"issue":"12","key":"4580_CR54","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1097\/ICO.0b013e318206895a","volume":"30","author":"A Fasolo","year":"2011","unstructured":"Fasolo A, Capuzzo C, Fornea M, Franch A, Birattari F, Carito G, Cucco F, Prosdocimo G, Sala M, Delle Noci N, et al. Risk factors for graft failure after penetrating keratoplasty: 5-year follow-up from the corneal transplant epidemiological study. Cornea. 2011;30(12):1328\u201335.","journal-title":"Cornea"},{"issue":"9","key":"4580_CR55","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41433-019-0717-3","volume":"34","author":"LY Zhai","year":"2020","unstructured":"Zhai LY, Zhang XR, Liu H, Ma Y, Xu HC. Observation of topical tacrolimus on high-risk penetrating keratoplasty patients: a randomized clinical trial study. Eye (Lond). 2020;34(9):1600\u20137.","journal-title":"Eye (Lond)"},{"issue":"2","key":"4580_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00417-015-3200-2","volume":"254","author":"JP Szaflik","year":"2016","unstructured":"Szaflik JP, Major J, Izdebska J, Lao M, Szaflik J. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study. Graefes Arch Clin Exp Ophthalmol. 2016;254(2):307\u201314.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"4580_CR57","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/eye.2008.402","volume":"23","author":"F Birnbaum","year":"2009","unstructured":"Birnbaum F, Mayweg S, Reis A, B\u00f6hringer D, Seitz B, Engelmann K, Messmer EM, Reinhard T. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study. Eye (Lond). 2009;23(11):2063\u201370.","journal-title":"Eye (Lond)"},{"issue":"11","key":"4580_CR58","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/bjophthalmol-2013-303639","volume":"97","author":"OA Magalhaes","year":"2013","unstructured":"Magalhaes OA, Marinho DR, Kwitko S. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study. Br J Ophthalmol. 2013;97(11):1395\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"4580_CR59","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.ophtha.2009.06.006","volume":"116","author":"AH Ross","year":"2009","unstructured":"Ross AH, Jones MN, Nguyen DQ, Jaycock PD, Armitage WJ, Cook SD, Kaye SB, Tole DM. Long-term topical steroid treatment after penetrating keratoplasty in patients with pseudophakic bullous keratopathy. Ophthalmology. 2009;116(12):2369\u201372.","journal-title":"Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04580-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04580-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04580-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:03:43Z","timestamp":1771247023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-025-04580-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4580"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04580-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Beijing Tongren Hospital (Approval No. TREC2019-03), and adhered to the tenets of the declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}